Huliq News Tagged: "peripheral vascular disease"

Syndicate content

Low-dose aspirin does not reduce risk of cerebrovascular events in diabetics

Low-dose aspirin as primary prevention did not appear to significantly reduce the risk of a combined end point of coronary, cerebrovascular and peripheral vascular events in patients with type 2 diabetes, according to a new study in JAMA. However, aspirin did significantly reduce the combination of fatal coronary and fatal cerebrovascular events.

Get the full story...

Adult stem cell application effective in treatment of peripheric vascular disease

Multipotent adult progenitor stem cells extracted from bone marrow, and known as MAPCs, have proved to be effective in the regeneration of blood vessel tissue and also in muscle tissue when treating peripheric vascular disease.

Get the full story...

Study looks at off-label use of biliary stents

Although approved by the U.S. Food and Drug Administration as a palliative treatment for cancer patients who have developed bile-duct obstructions, biliary stents are sometimes used “off-label” for the treatment of peripheral vascular disease (PVD).

Get the full story...

Key to blood vessel growth, possible drug target identified

Researchers have identified a molecular pathway that plays a critical role in the growth of blood vessels. The finding not only offers an important insight into the development of the vascular system during embryonic development but suggests a potential target for inhibiting the blood vessels that fuel cancers, diabetic eye complications and atherosclerosis, the researchers say.

Get the full story...

CT angiography can replace digital subtraction angiography

CT angiography (CTA) alone is an effective, noninvasive means to detect peripheral vascular disease, according to a study conducted by researchers at Charite Campus Benjamin Franklin in Berlin, Germany.

Get the full story...

Best treatment approach for narrowed kidney arteries

Whether reopening narrowed kidney arteries benefits patients is a $1.7 billion question a North American study hopes to answer.

Read the full story